Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2013, Article ID 469097, 9 pages
http://dx.doi.org/10.1155/2013/469097
Clinical Study

Surveillance of HCC Patients after Liver RFA: Role of MRI with Hepatospecific Contrast versus Three-Phase CT Scan—Experience of High Volume Oncologic Institute

1Division of Radiology, Department of Diagnostic Imaging, Radiant and Metabolic Therapy, “Istituto Nazionale Tumori Fondazione Giovanni Pascale-IRCCS”, Via Mariano Semmola, 80131 Naples, Italy
2Division of Hepato-Biliary Surgery, Department of Abdominal Oncology, “Istituto Nazionale Tumori Fondazione Giovanni Pascale-IRCCS”, Via Mariano Semmola, 80131 Naples, Italy

Received 29 August 2013; Accepted 3 October 2013

Academic Editor: Monica Lupsor Platon

Copyright © 2013 Vincenza Granata et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma,” Hepatology, vol. 42, no. 5, pp. 1208–1236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Unek, S. Karademir, N. C. Arslan et al., “Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 17, no. 37, pp. 4206–4212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. A. Curley and F. Izzo, “Radiofrequency ablation of primary and metastatic hepatic malignancies,” International Journal of Clinical Oncology, vol. 7, no. 2, pp. 72–81, 2002. View at Google Scholar · View at Scopus
  4. S. A. Curley and F. Izzo, “Radiofrequency ablation of hepatocellular carcinoma,” Minerva Chirurgica, vol. 57, no. 2, pp. 165–176, 2002. View at Google Scholar · View at Scopus
  5. S. A. Curley, F. Izzo, L. M. Ellis, J. N. Vauthey, and P. Vallone, “Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis,” Annals of Surgery, vol. 232, no. 3, pp. 381–391, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. T. M. Pawlik, F. Izzo, D. S. Cohen, J. S. Morris, and S. A. Curley, “Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients,” Annals of Surgical Oncology, vol. 10, no. 9, pp. 1059–1069, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. S. A. Curley, P. Marra, K. Beaty et al., “Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients,” Annals of Surgery, vol. 239, no. 4, pp. 450–458, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Corner, C. Ayuso, M. Varala et al., “Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma. are response evaluation criteria in solid tumors reliable?” Cancer, vol. 115, no. 3, pp. 616–623, 2009. View at Publisher · View at Google Scholar
  9. P. Therasse, S. G. Arbuck, E. A. Eisenhauer et al., “New guidelines to evaluate the response to treatment in solid tumors,” Journal of the National Cancer Institute, vol. 92, no. 3, pp. 205–216, 2000. View at Google Scholar · View at Scopus
  10. S. K. Kim, H. K. Lim, Y. H. Kim et al., “Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings,” Radiographics, vol. 23, no. 1, pp. 107–121, 2003. View at Google Scholar · View at Scopus
  11. A. S. Kierans, M. Elazzazi, L. Braga et al., “Thermoablative treatments for malignant liver lesions: 10-Year experience of MRI appearances of treatment response,” American Journal of Roentgenology, vol. 194, no. 2, pp. 523–529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. H. K. Lim, D. Choi, W. J. L. Won Jae Lee et al., “Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT,” Radiology, vol. 221, no. 2, pp. 447–454, 2001. View at Google Scholar · View at Scopus
  13. T. J. Vogl, S. Kümmel, R. Hammerstingl et al., “Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA,” Radiology, vol. 200, no. 1, pp. 59–67, 1996. View at Google Scholar · View at Scopus
  14. L. Bolondi, S. Gaiani, N. Celli et al., “Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma,” Hepatology, vol. 42, no. 1, pp. 27–34, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Huppertz, S. Haralda, A. Kraus et al., “Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations,” Radiology, vol. 234, no. 2, pp. 468–478, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Joseph and C. Reinhold, “Statistical inference for proportions,” American Journal of Roentgenology, vol. 184, no. 4, pp. 1057–1064, 2005. View at Google Scholar · View at Scopus
  17. N. E. D. Hawass, “Comparing the sensitivities and specificities of two diagnostic procedures performed on the same group of patients,” British Journal of Radiology, vol. 70, pp. 360–366, 1997. View at Google Scholar · View at Scopus
  18. N. A. Obuchowski, “ROC analysis,” American Journal of Roentgenology, vol. 184, pp. 364–372, 2005. View at Publisher · View at Google Scholar
  19. F. S. Ferrari, A. Megliola, A. Scorzelli et al., “Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of techniques and long-term results,” Radiologia Medica, vol. 112, no. 3, pp. 377–393, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Stoffner, P. Schullian, G. Widmann, R. Bale, and C. Kremser, “Magnetic resonance imaging of radiofrequency current-induced coagulation zones in the EX vivo bovine liver,” RöFo, vol. 182, no. 8, pp. 690–697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. K. Kim, H. K. Lim, Y. H. Kim et al., “Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings,” Radiographics, vol. 23, no. 1, pp. 107–121, 2003. View at Google Scholar · View at Scopus
  22. U. Motosugi, T. Ichikawa, H. Sou et al., “Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging,” Radiology, vol. 256, no. 1, pp. 151–158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Di Martino, D. Marin, A. Guerrisi et al., “Intraindividual comparison of gadoxetate disodium—enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis,” Radiology, vol. 256, no. 3, pp. 806–816, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Watanabe, M. Kanematsu, S. Goshima et al., “Is gadoxetate disodium-enhanced MRI useful for detecting local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy?” American Journal of Roentgenology, vol. 198, no. 3, pp. 589–595, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. U. Motosugi, T. Ichikawa, H. Sou et al., “Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging,” Radiology, vol. 256, no. 1, pp. 151–158, 2010. View at Publisher · View at Google Scholar · View at Scopus